Intranasal delivery of BDNF-loaded small extracellular vesicles for cerebral ischemia therapy.

[1]  Yong Cheng,et al.  Intranasal Administration of Brain-Derived Neurotrophic Factor Rescues Depressive-Like Phenotypes in Chronic Unpredictable Mild Stress Mice , 2022, Neuropsychiatric disease and treatment.

[2]  P. Song,et al.  Micro-RNA let-7a-5p Derived From Mesenchymal Stem Cell-Derived Extracellular Vesicles Promotes the Regrowth of Neurons in Spinal-Cord-Injured Rats by Targeting the HMGA2/SMAD2 Axis , 2022, Frontiers in Molecular Neuroscience.

[3]  Chaoying Hu,et al.  Analgecine protects against cerebral ischemia-reperfusion through apoptosis inhibition and anti-neuroinflammation in rats , 2022, Neuropeptides.

[4]  Minhyung Lee,et al.  Hypoxia-specific anti-RAGE exosomes for nose-to-brain delivery of anti-miR-181a oligonucleotide in an ischemic stroke model. , 2021, Nanoscale.

[5]  Zixiao Li,et al.  Research Progress on PATJ and Underlying Mechanisms Associated with Functional Outcomes After Stroke , 2021, Neuropsychiatric disease and treatment.

[6]  Xue Wang,et al.  miR-100-5p in human umbilical cord mesenchymal stem cell-derived exosomes mediates eosinophilic inflammation to alleviate atherosclerosis via the FZD5/Wnt/β-catenin pathway. , 2021, Acta biochimica et biophysica Sinica.

[7]  Yucong Peng,et al.  Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke , 2021, Stem cells international.

[8]  C. Lenahan,et al.  Insight Into the Mechanisms and the Challenges on Stem Cell-Based Therapies for Cerebral Ischemic Stroke , 2021, Frontiers in Cellular Neuroscience.

[9]  Guo-Yuan Yang,et al.  Therapeutic application of exosomes in ischaemic stroke , 2021, Stroke and vascular neurology.

[10]  F. Volpicelli,et al.  Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer , 2020, International journal of molecular sciences.

[11]  S. Kuroda,et al.  Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke , 2020, International journal of molecular sciences.

[12]  M. Soleimani,et al.  Stem Cell-Derived Exosomes as Treatment for Stroke: a Systematic Review , 2020, Stem Cell Reviews and Reports.

[13]  L. Maffei,et al.  Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis , 2020, Aging Clinical and Experimental Research.

[14]  M. Hamblin,et al.  Human neural stem cells improve early stage stroke outcome in delayed tissue plasminogen activator-treated aged stroke brains , 2020, Experimental Neurology.

[15]  V. Feigin,et al.  Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: A Systematic Analysis of the Global Burden of Disease Study 2017 , 2020, Neuroepidemiology.

[16]  Wei Liu,et al.  Brain-Derived Neurotrophic Factor and Its Potential Therapeutic Role in Stroke Comorbidities , 2020, Neural plasticity.

[17]  Jung Min Lee,et al.  Current Knowledge and Future Perspectives on Mesenchymal Stem Cell-Derived Exosomes as a New Therapeutic Agent , 2020, International journal of molecular sciences.

[18]  S. Zheng,et al.  Small extracellular vesicles derived from human mesenchymal stromal cells prevent group 2 innate lymphoid cell-dominant allergic airway inflammation through delivery of miR-146a-5p , 2020, Journal of extracellular vesicles.

[19]  Wei Zhou,et al.  Let-7f-5p ameliorates inflammation by targeting NLRP3 in bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  J. Granneman,et al.  MicroRNA-10a-5p regulates macrophage polarization and promotes therapeutic adipose tissue remodeling , 2019, Molecular metabolism.

[21]  P. Ji,et al.  Exosomes of stem cells from human exfoliated deciduous teeth as an anti-inflammatory agent in temporomandibular joint chondrocytes via miR-100-5p/mTOR , 2019, Stem Cell Research & Therapy.

[22]  Chen-Yu Zhang,et al.  Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis , 2019, Aging.

[23]  M. Teixeira,et al.  Tissue Dependent Role of PTX3 During Ischemia-Reperfusion Injury , 2019, Front. Immunol..

[24]  David T. Jones,et al.  Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases. , 2019, Mayo Clinic proceedings.

[25]  M. Chopp,et al.  Exosomes — beyond stem cells for restorative therapy in stroke and neurological injury , 2019, Nature Reviews Neurology.

[26]  Y. Tabata,et al.  Neural Stem Cells Transfected with Reactive Oxygen Species–Responsive Polyplexes for Effective Treatment of Ischemic Stroke , 2019, Advanced materials.

[27]  P. Garred,et al.  Pentraxins in Complement Activation and Regulation , 2018, Front. Immunol..

[28]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[29]  Jinghua Lu,et al.  Pentraxins and Fc Receptor-Mediated Immune Responses , 2018, Front. Immunol..

[30]  J. Cha,et al.  Application of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Stroke: Biodistribution and MicroRNA Study , 2018, Translational Stroke Research.

[31]  R. Rizzi,et al.  Potential of Stem Cell-Based Therapy for Ischemic Stroke , 2018, Front. Neurol..

[32]  Jianbo Shi,et al.  Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells , 2017, Stem Cell Research & Therapy.

[33]  Emiri T. Mandeville,et al.  Astrocyte-Derived Pentraxin 3 Supports Blood–Brain Barrier Integrity Under Acute Phase of Stroke , 2016, Stroke.

[34]  H. Zhuang,et al.  Downregulation of let-7e-5p contributes to endothelial progenitor cell dysfunction in deep vein thrombosis via targeting FASLG. , 2016, Thrombosis research.

[35]  Junfa Li,et al.  Micro‐RNA‐30a regulates ischemia‐induced cell death by targeting heat shock protein HSPA5 in primary cultured cortical neurons and mouse brain after stroke , 2015, Journal of neuroscience research.

[36]  F. Barry,et al.  Bone Marrow‐Derived Mesenchymal Stem Cells Have Innate Procoagulant Activity and Cause Microvascular Obstruction Following Intracoronary Delivery: Amelioration by Antithrombin Therapy , 2015, Stem cells.

[37]  Ryan M. O’Connell,et al.  Exosome-delivered microRNAs modulate the inflammatory response to endotoxin , 2015, Nature Communications.

[38]  C. Garlanda,et al.  Pentraxin 3 mediates neurogenesis and angiogenesis after cerebral ischaemia , 2015, Journal of Neuroinflammation.

[39]  C. Théry,et al.  Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. , 2014, Annual review of cell and developmental biology.

[40]  Angel F. Lopez,et al.  14-3-3ε and ζ Regulate Neurogenesis and Differentiation of Neuronal Progenitor Cells in the Developing Brain , 2014, The Journal of Neuroscience.

[41]  J. Filosa,et al.  A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion , 2013, Journal of Neuroinflammation.

[42]  L. Monteggia,et al.  Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders , 2012, Pharmacological Reviews.

[43]  Gelin Xu,et al.  Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats , 2011, Neuroscience.

[44]  A. Alexander,et al.  Diffusion tensor imaging of the brain , 2007, Neurotherapeutics.

[45]  Muzamil Ahmad,et al.  Inflammation After Stroke: Mechanisms and Therapeutic Approaches , 2010, Translational Stroke Research.

[46]  W. Frey,et al.  Intranasal delivery to the central nervous system: mechanisms and experimental considerations. , 2010, Journal of pharmaceutical sciences.

[47]  Joanna Wardlaw,et al.  Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial , 2009, The Lancet Neurology.

[48]  C. Sommer,et al.  Intravenous Brain-Derived Neurotrophic Factor Enhances Poststroke Sensorimotor Recovery and Stimulates Neurogenesis , 2007, Stroke.

[49]  K. Weinberg,et al.  The Role of the Hyaluronan Receptor CD44 in Mesenchymal Stem Cell Migration in the Extracellular Matrix , 2006, Stem cells.

[50]  L. Lejeune,et al.  Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. , 2005, Blood.

[51]  M. Chopp,et al.  Atorvastatin Induction of VEGF and BDNF Promotes Brain Plasticity after Stroke in Mice , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[52]  W. Pardridge,et al.  Carboxyl-directed Pegylation of Brain-derived Neurotrophic Factor Markedly Reduces Systemic Clearance with Minimal Loss of Biologic Activity , 1997, Pharmaceutical Research.

[53]  D. Ledbetter,et al.  14-3-3ε is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller–Dieker syndrome , 2003, Nature Genetics.